Goldenwell Biotech Profit Margin

Goldenwell Biotech (GWLL) currently reports a profit margin of -1130.45% as of June 2026. That compares with -241.55% in the prior-year period — down 368.0% year over year. That is below the sector sector average of 13.23%. Use the charts on this page to explore Goldenwell Biotech's profit margin history and peer comparisons.

Goldenwell Biotech's profit margin decreased from -241.55% to -1130.45% — a 368.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Goldenwell Biotech's profit margin of -1130.45% is lower than the its sector sector average of 13.23%. That is roughly 8647.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Goldenwell Biotech's current -1130.45% should be judged against industry norms (sector average: 13.23%) and against GWLL's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1130.45%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.23%. From there, open related valuation or income-statement pages for Goldenwell Biotech, and consider following GWLL for alerts when major investors trade the stock.